DekaBank Deutsche Girozentrale’s Rocket Pharmaceuticals RCKT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-89,700	Closed	-$2.66M	–	1305
2025 Q4	$2.66M	Hold	89,700	–	–	﹤0.01%	704
2025 Q3	$273K	Hold	89,700	–	–	﹤0.01%	1083
2025 Q2	$208K	Hold	89,700	–	–	﹤0.01%	1119
2025 Q1	$639K	Hold	89,700	–	–	﹤0.01%	921
2024 Q4	$1.01M	Hold	89,700	–	–	﹤0.01%	873
2024 Q3	$1.61M	Hold	89,700	–	–	﹤0.01%	798
2024 Q2	$1.92M	Hold	89,700	–	–	﹤0.01%	773
2024 Q1	$2.42M	Hold	89,700	–	–	﹤0.01%	721
2023 Q4	$2.77M	Hold	89,700	–	–	0.01%	708
2023 Q3	$1.85M	Hold	89,700	–	–	﹤0.01%	757
2023 Q2	$1.8M	Hold	89,700	–	–	﹤0.01%	772
2023 Q1	$1.44M	Hold	89,700	–	–	﹤0.01%	794
2022 Q4	$1.72M	Hold	89,700	–	–	﹤0.01%	757
2022 Q3	$1.24M	Sell	89,700 -60,500	-40%	-$944K	﹤0.01%	819
2022 Q2	$1.92M	Hold	150,200	–	–	0.01%	739
2022 Q1	$2.4M	Buy	150,200 +18,700	+14%	+$323K	0.01%	712
2021 Q4	$2.94M	Buy	131,500 +2,200	+2%	+$60K	0.01%	689
2021 Q3	$3.84M	Hold	129,300	–	–	0.01%	592
2021 Q2	$5.52M	Buy	129,300 +75,000	+138%	+$3.26M	0.02%	501
2021 Q1	$2.32M	Buy	54,300 +7,000	+15%	+$384K	0.01%	659
2020 Q4	$2.61M	Sell	47,300 -26,400	-36%	-$962K	0.01%	606
2020 Q3	$1.68M	Buy	+73,700	New	+$1.82M	0.01%	626
2016 Q2	–	Sell	-2,875	Closed	-$85K	–	1032
2016 Q1	$85K	Buy	+2,875	New	+$86.3K	﹤0.01%	983

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale's RCKT Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 89,700 shares — an estimated $2.66M sold.

DekaBank Deutsche Girozentrale first reported a position in RCKT in Q1 2016 and held it in 23 quarters. The position peaked at $5.52M in Q2 2021. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 89,700 Rocket Pharmaceuticals shares in Q1 2026, an estimated $2.66M.
DekaBank Deutsche Girozentrale first reported a position in Rocket Pharmaceuticals in Q1 2016 and held it in 23 quarters.
DekaBank Deutsche Girozentrale's Rocket Pharmaceuticals position peaked at $5.52M in Q2 2021.
199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.